Who Truly Benefits From Pre-Publishing and Rushing Publishing?

“…who will benefit from the release of such data earlier? Neither the general public nor the practicing clinician will benefit, as they may be confused by potentially conflicting data and recommendations, if unreviewed manuscripts are equally as discoverable as peer-reviewed papers. Thus, I would propose that manuscript authors are the only ones who may benefit from the process. They can promote their “publication” on social media and within their departments, but these manuscripts should not maintain the same level of credibility as peer-reviewed papers. Maybe, the medical community could all benefit from a little patience.”

 

Comments are closed.

Proudly powered by WordPress | Theme: Baskerville 2 by Anders Noren.

Up ↑